A novel mechanism of murine hepatocyte death inducible by Concanavalin A

Journal of Hepatology

Volumn 25, Issue 6, 1996, Pages 948-959

  Leist, Marcel ^b   Wendel, Albrecht ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b NONE

Author keywords

Cytotoxicity; Glutathione; Lectin; Liver; Taxol

Indexed keywords

CONCANAVALIN A; DNA FRAGMENT; GLUTATHIONE; LECTIN; PACLITAXEL; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; MALE; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; T LYMPHOCYTE ACTIVATION;

EID: 0011182563     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80301-1     Document Type: Article

References (49)

1. 1. Liener IE, Isolation and properties of concanavalin A. In: Bittiger H, Schnebli HP, eds. Concanavalin A as a tool. New York: John Wiley & Sons, 1976: 17-32.
2. 2. Becker JW, Cunningham BA, Wang JL, Edelman GM. The molecular structure of concanavalin A. In: Bittiger H, Schnebli HP, eds. Concanavalin A as a tool. New York: John Wiley & Sons, 1976: 33-56.
3. 3. Gunther GR, Wang JL, Yahara I, Cunningham BA, Edelman GM. Concanavalin A derivatives with altered biological activities. Proc Natl Acad Sci USA 1973; 70: 1012-6.
4. 4. Griswold DE, Antell L, Bender PE, Hanna N, Poste G. Induction of suppressor cells, interleukin-2 production and mitogenesis with monomeric concanavalin A: different actions of tetrameric and monomeric concanavalin A. Mol Immunol 1985; 22: 1311-6.
5. 5. Goldstein IJ. Carbohydrate binding specificity of concanavalin A. In: Bittiger H, Schnebli HP, eds. Concanavalin A as a tool. New York: John Wiley & Sons, 1976: 57-68.
6. 6. Sharon N. Lectin-carbohydrate complexes of plants and animals: an atomic view. Trends Biochem Sci 1993; 18: 221-6.
7. 7. Barondes SH. Bifunctional properties of lectins: lectins redefined. Trends Biochem Sci 1988; 13: 480-2.
8. 8. Drickamer K. Two distinct classes of carbohydrate-recognition domains in animal lectins. J Biol Chem 1988; 263: 9557-60.
9. 9. Kuan SF, Persson A, Parghi D, Crouch E. Lectin-mediated interactions of surfactant protein D with alveolar macrophages. Am J Respir Cell Mol Biol 1994; 10: 430-6.
10. 10. Leist M, Gantner F, Jilg S, Wendel A. Activation of the 55 kDa TNF-receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis and nitrite release. J Immunol 1995; 154: 1307-16.
11. 11. Hession C, Decker JM, Sherblom AP, Kumar S, Yue CC, Mattaliano RJ, Tizard R, et al. Uromodulin (Tamm-Horsfall Glycoprotein): A renal ligand for lymphokines. Science 1987; 237: 1479-84.
12. 12. Lucas R, Magez S, De Leys R, Fransen L, Scheerlinck JP, Rampelberg M, Sablon E, De Baetselier P. Mapping of the lectin-like activity of tumor necrosis factor. Science 1994; 263: 814-7.
13. 13. Goeddel DV, Aggarwal BB, Gray PW, Leung DW, Nedwin GE, Palladino MA, Patton JS, Pennica D, Shepard HM, Sugarman BJ, Wong GHW. Tumor necrosis factors: gene structure and biological activities. Cold Spring Harbor Symp Quant Biol 1986; 51: 597-609.
14. 14. Peschke T, Wollweber L, Gabert A, Augsten K, Stracke R. Effect of different fixatives on Con A surface receptors of mouse peritoneal macrophages. Histochem 1990; 93: 443-6.
15. 15. Pink JR, Hoessli D, Tartakoff A, Hooghe R. Characterisation of Con A-binding glycoproteins from mouse splenic leukocytes by two-dimensional electrophoresis: preferential binding of incompletely glycosylated forms of H-2 antigen to the lectin. Immunol 1983; 20: 491-7.
16. 16. McMillan PN, Ferayorni LS, Gerhardt CO, Jauregui HO. Light and electron microscope analysis of lectin binding to adult rat liver in situ. Lab Invest 1984; 50: 408-20.
17. 17. Ozanne O, Sambrook J. Binding of radioactively labelled concanavalin A and wheat germ agglutinin to normal and virus-transformed cells. Nature New Biol 1971; 232: 156-60.
18. 18. Cline MJ, Livingston DC. Binding of 3-H-concanavalin A by normal and transformed cells. Nature New Biol 1971; 232: 155-6.
19. 19. Katzen HM, Vicario PP, Mumford RA, Green BG. Evidence that the insulin-like activities of concanavalin A and insulin are mediated by a common insulin receptor linked effector system. Biochemistry 1981; 20: 5800-9.
20. 20. Shechter O. Bound lectins that mimic insulin produce persistent insulin-like activities. Endocrinology 1983; 113: 1921-6.
21. 21. diSabato G, Hall JM, Thompson LA. T cell mitogens and polyclonal B cell activators. Meth Enzymol 1989; 150: 3-17.
22. 22. Taniguchi K, Kawano Y, Toshitani A, Karashima A, Nomoto K. Anti-metastatic effect by in vivo administration of concanavalin athrough augmentation of T derived activated killer activity: efficacy to B16 melanoma expressed MHC antigen. Cell Immunol 1989; 120: 460-9.
23. 23. Shier WT. Concanavalin A as an inflammogen. In: Bittiger H, Schnebli HP, eds. Concanavalin A as a tool. New York: John Wiley & Sons, 1976; 573-80.
24. 24. Ralph P. Differential toxicity of concanavalin A and PHA on lymphoid and hematopoietic cell lines. In: Bittiger H, Schnebli HP, eds. Concanavalin A as a tool. New York: John Wiley & Sons, 1976; 613-22.
25. 25. Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible to concanavalin A. J Clin Invest 1992; 90: 196-203.
26. 26. Mizuhara H, O'Neill E, Seki N, Ogawa T, Kusunoki C, Otsuka K, Satoh S, Niwa M, Senoh H, Fujiwara H. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 1994; 179: 1529-37.
27. 27. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G. Concanavalin A-induced T cell-mediated hepatic injury in mice: The role of tumor necrosis factor. Hepatology 1995; 21: 190-8.
28. 28. Ferran C, Sheehan K, Dy M, Schreiber R, Merite S, Landais P, Noel LH, Grau G, et al. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur J Immunol 1990; 20: 509-15.
29. 29. Marrack P, Blackman M, Kushnir E, Kappler J. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J Exp Med 1990; 171: 455-64.
30. 30. Decker K, Keppler D. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev Physiol Biochem Pharmacol 1974; 71: 77-100.
31. 31. Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH, Wagner H. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med 1992; 175: 91-8.
32. 32. Gantner F, Leist M, Jilg S, German PG, Freudenberg MA, Tiegs G. Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice. Gastroenterology 1995; 109: 166-76.
33. 33. Nagaki M, Muto Y, Ohnishi H, Yasuda S, Sano K, Naito T, Maeda T, Yamada T, Moriwaki H. Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B. Gastroenterology 1994; 106: 450-8.
34. 34. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995; 146: 1220-34.
35. 35. Rothe J, Lesslauer W, Lötscher H, Lang Y, Koebel P, Königen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by listeria monocytogenes. Nature 1993; 364: 798-800.
36. 36. Seglen PO. Preparation of rat liver cells: Enzymatic requirements for tissue dispersion. Exp Cell Res 1973; 82: 391-8.
37. 37. Kleiman NJ, Friedman DL, diSabato G. Preparation of single cell suspensions from lymphoid organs. Meth Enzymol 1984; 108: 43-9.
38. 38. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidised glutathione: application to mammalian blood and other tissues. Anal Biochem 1969; 27: 502-22.
39. 39. Bergmeyer HU. Methods of enzymatic analysis, 3rd edn. Weinheim, Germany: Verlag Chemie, 1984.
40. 40. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth 1983; 65: 55-63.
41. 41. McConkey DJ, Hartzell P, Nicotera P, Orrenius S. Calcium-activated DNA fragmentation kills immature thymocytes. Faseb J 1989; 3: 1843-9.
42. 42. Leist M, Gantner F, Bohlinger I, German PG, Tiegs G, Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J Immunol 1994; 153: 1778-87.
43. 43. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
44. 44. Sigma Product Catalogue. 1994; 1799-802.
45. 45. De Brabander M, Geuens G, Nuydens R, Willebrords R, DeMey F. Taxol induces the assembly of free microtubules in living cells and blocks the organizing capacity of the centrosomes and kinetochores. Proc Natl Acad Sci USA 1981; 78: 5608-12.
46. 46. Leist M, Gantner F, Bohlinger I, Künstle G, Bluethmann H, Tiegs G, Wendel A. Fas and the 55 kDa tumor necrosis factor receptor: two independent receptors signalling murine apoptotic hepatocyte death and liver failure. Mol Med 1995; 2: 109-24.
47. 47. Berke G, McVey E, Hu V Clark WR. T lymphocyte-mediated cytolysis: II. Role of target cell histocompatibility antigens in recognition and lysis. J Immunol 1981; 127: 782-7.
48. 48. Bette P, Oksche A, Mauler F, Eichel-Streiber C, Popoff MR, Habermann E. A comparative biochemical, pharmacological and immunological study of Clostridium novyi α-toxin, C. difficile toxin B and C. sordellii lethal toxin. Toxicon 1991; 29: 877-87.
49. 49. Fiorentini C, Malorni W, Paradisi S, Giuliano M, Mastrantonio P, Donelli G. Interaction of Clostridium difficile toxin A with cultured cells: cytoskeletal changes and nuclear polarization. Infect Immun 1990; 58: 2329-36.